Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy.
暂无分享,去创建一个
K. Rother | P. Gorden | Rebecca J. Brown | M. Collins | J. Reynolds | E. Cochran | R. Gafni | A. Lungu | John Christensen
[1] B. Zemel. Bone mineral accretion and its relationship to growth, sexual maturation and body composition during childhood and adolescence. , 2013, World review of nutrition and dietetics.
[2] M. Cooper,et al. Diagnostic evaluation of bone densitometric size adjustment techniques in children with and without low trauma fractures , 2013, Osteoporosis International.
[3] C. Rosen,et al. Understanding leptin-dependent regulation of skeletal homeostasis. , 2012, Biochimie.
[4] R. Considine,et al. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. , 2012, The Journal of clinical endocrinology and metabolism.
[5] I. Farooqi,et al. Leptin Substitution Results in the Induction of Menstrual Cycles in an Adolescent with Leptin Deficiency and Hypogonadotropic Hypogonadism , 2012, Hormone Research in Paediatrics.
[6] T. Hangartner,et al. Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. , 2011, The Journal of clinical endocrinology and metabolism.
[7] S. O’Rahilly,et al. Genetic syndromes of severe insulin resistance. , 2011, Endocrine reviews.
[8] T. Maeda,et al. Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1α,25‐dihydroxyvitamin D3 synthesis in leptin‐deficient ob/ob Mice , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[9] S. Heymsfield,et al. Dual Energy X-Ray Absorptiometry Body Composition Reference Values from NHANES , 2009, PloS one.
[10] I. Reid,et al. In vitro and in vivo effects of adiponectin on bone. , 2009, Endocrinology.
[11] J. Jürimäe,et al. Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. , 2007, American journal of physiology. Endocrinology and metabolism.
[12] S. Kalra,et al. Central leptin gene therapy corrects skeletal abnormalities in leptin-deficient ob/ob mice , 2007, Peptides.
[13] P. Gorden,et al. Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy. , 2007, Metabolism: clinical and experimental.
[14] J. Tobias,et al. Association Between Bone Mass and Fractures in Children: A Prospective Cohort Study , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[15] S. O’Rahilly,et al. Elevated plasma adiponectin in humans with genetically defective insulin receptors. , 2006, The Journal of clinical endocrinology and metabolism.
[16] S. Holland,et al. Leptin replacement therapy modulates circulating lymphocyte subsets and cytokine responsiveness in severe lipodystrophy. , 2006, The Journal of clinical endocrinology and metabolism.
[17] P. Gorden,et al. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. , 2005, Diabetes.
[18] M. Hamrick,et al. Leptin Treatment Induces Loss of Bone Marrow Adipocytes and Increases Bone Formation in Leptin‐Deficient ob/ob Mice , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] D. Kleiner,et al. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy , 2005, Hepatology.
[20] A. Volpe,et al. Recombinant human leptin in women with hypothalamic amenorrhea. , 2004, The New England journal of medicine.
[21] P. Gorden,et al. Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy. , 2004, Metabolism: clinical and experimental.
[22] D. Xie,et al. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. , 2004, Bone.
[23] A. Garg,et al. Clinical Features and Metabolic Derangements in Acquired Generalized Lipodystrophy: Case Reports and Review of the Literature , 2003, Medicine.
[24] J. Zerwekh,et al. Effect of subcutaneous leptin replacement therapy on bone metabolism in patients with generalized lipodystrophy. , 2002, The Journal of clinical endocrinology and metabolism.
[25] Graham M Lord,et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. , 2002, The Journal of clinical investigation.
[26] K. Petersen,et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. , 2002, The Journal of clinical investigation.
[27] M. Reitman,et al. Leptin-replacement therapy for lipodystrophy. , 2002, The New England journal of medicine.
[28] C. Steppan,et al. Leptin is a potent stimulator of bone growth in ob/ob mice , 2000, Regulatory Peptides.
[29] Arndt F Schilling,et al. Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass , 2000, Cell.
[30] A. Prentice,et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. , 1999, The New England journal of medicine.
[31] R. Hammer,et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy , 1999, Nature.
[32] W. Greulich,et al. Radiographic Atlas of Skeletal Development of the Hand and Wrist , 1999 .
[33] Stephen R. Bloom,et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression , 1998, Nature.
[34] F. Chehab,et al. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin , 1996, Nature Genetics.
[35] Steven L. Cohen,et al. Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.
[36] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.
[37] M. Haussler,et al. Molecular Mechanisms of Vitamin D Action , 2012, Calcified Tissue International.
[38] P. Gorden,et al. Efficacy of leptin therapy in the different forms of human lipodystrophy , 2009, Diabetologia.
[39] Steven R Smith,et al. A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. , 1998, Endocrinology.
[40] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.